Week in Review
Congress passes additional legislation to combat COVID-19, the D.C. Circuit hears oral arguments by phone, and more…
Combatting Covert Chemistry Operations
To curb overdoses and drug trafficking, the DEA proposes regulations for a chemical precursor to fentanyl.
Week in Review
CMS issues temporary waivers to hospitals amid the coronavirus pandemic, the Trump Administration rolls back vehicle emissions standards, and more…
An Epidemic Meets a Pandemic
Amid the coronavirus, the federal government eases restrictions on prescribing controlled substances by telehealth.
The Regulatory Race Against a Public Health Crisis
The federal government responds to the coronavirus pandemic by amending its foreign quarantine rules.
Proposed Rule Seeks to Promote Value-Based Health Care
Federal regulators seek to expand safe harbors for provider care coordination arrangements.
Relaxing Patient Privacy Laws to Tackle Substance Abuse
To fight opioid misuse, the U.S. government proposes expanding access to medical records on substance use.
The Regulatory Battle Over Safe Injection Sites
As the United States struggles with opioid addiction, litigation rages over medically supervised consumption facilities.